Previous 10 | Next 10 |
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Steffen Hellmold, senior vice president, business development for data storage, will participate i...
Twist Bioscience (NASDAQ:TWST) said it signed a collaboration and exclusive option license agreement with Astellas Pharma (OTCPK:ALPMF) (OTCPK:ALPMY) for antibodies to reduce tumor microenvironment-mediated immunosuppression. Under the agreement, the companies will jointly conduct resear...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has entered into a research collaboration and exclusive option license agreement with Astellas Pharma In...
The following slide deck was published by Twist Bioscience Corporation in conjunction with their 2022 Q2 earnings call. For further details see: Twist Bioscience Corporation 2022 Q2 - Results - Earnings Call Presentation
Twist Bioscience Corp (TWST) Q2 2022 Earnings Conference Call May 05, 2022, 16:30 ET Company Participants Angela Bitting - Chief ESG Officer & SVP, Corporate Affairs Emily Leproust - Co-Founder, Chairman, President & CEO James Thorburn - CFO Conference Call Participants Matthew Sykes ...
Twist Bioscience press release (NASDAQ:TWST): FQ2 GAAP EPS of -$1.13 beats by $0.14. Revenue of $48.13M (+54.3% Y/Y) beats by $2.88M. As of March 31, 2022, the company had $604.4 million in cash, cash equivalents and investments. Total orders received for the second quarter of fiscal 2022 wer...
-- Record revenue of $48.1M in 2QFY22; Increase of 54% over $31.2M in Fiscal 2021 – -- Orders Increased 32% in 2QFY22 over Fiscal 2021 to $55.0M -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-qu...
Gainers: TransMedics Group (TMDX) +17%. Rigel Pharmaceuticals (RIGL) +9%. CarParts.com (PRTS) +9%. Super Micro Computer (SMCI) +9%. Twist Bioscience Corporation (TWST) +8%. Losers: Lyft (LYFT) -24%. Kezar Life Sciences (KZR)-24%. Infinera Corporation (INFN) ...
-- Writing the Future of Biologics Presentation on May 2 -- -- Rapid, Function-Forward mAb Discovery against a Cell Surface Target via Concurrent Use of Humanized and Hyperimmune Mice Presentation on May 4 -- Twist Bioscience Corporation (NASDAQ: TWST), a company enablin...
-- Gene to Antibody Production Workflow Enables Customers to Turn Digital DNA Sequences into Purified IgG Antibodies -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of synthetic DNA using its silicon platform, toda...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...